Application of curcumin nanoformulations in Alzheimer’s disease: prevention, diagnosis and treatment
暂无分享,去创建一个
[1] Fen-fang Hong,et al. Role of Cholinergic Signaling in Alzheimer’s Disease , 2022, Molecules.
[2] Wenyi Wei,et al. The regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer's disease. , 2022, Acta materia medica.
[3] Wenyi Wei,et al. PROTACs technology for treatment of Alzheimer's disease: Advances and perspectives. , 2022, Acta materia medica.
[4] S. Sohn,et al. Biomedical Applications and Bioavailability of Curcumin—An Updated Overview , 2021, Pharmaceutics.
[5] A. Gavin,et al. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes , 2021, bioRxiv.
[6] M. Asti,et al. Applications of Radiolabelled Curcumin and Its Derivatives in Medicinal Chemistry , 2021, International journal of molecular sciences.
[7] S. Prasad,et al. Metal–Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin , 2021, International journal of molecular sciences.
[8] U. Stochaj,et al. Curcumin nanoformulations to combat aging-related diseases , 2021, Ageing Research Reviews.
[9] I. Doytchinova,et al. Effects of Curcumin and Ferulic Acid on the Folding of Amyloid-β Peptide , 2021, Molecules.
[10] A. Tyagi,et al. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology , 2020, International journal of molecular sciences.
[11] T. Farkhondeh,et al. The role of curcumin in aging and senescence: Molecular mechanisms. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] Xiaofeng Lin,et al. A Novel Nanosystem Realizing Curcumin Delivery Based on Fe3O4@Carbon Dots Nanocomposite for Alzheimer’s Disease Therapy , 2020, Frontiers in Bioengineering and Biotechnology.
[13] D. Holtzman,et al. Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis , 2020, Neuron.
[14] A. Tsatsakis,et al. Curcumin Formulations and Trials: What’s New in Neurological Diseases , 2020, Molecules.
[15] G. Perale,et al. In vivo drug delivery applications of nanogels: a review. , 2020, Nanomedicine.
[16] Shuyu Xie,et al. Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences. , 2020, Advances in colloid and interface science.
[17] M. Corbo,et al. Obstacles against the Marketing of Curcumin as a Drug , 2020, International journal of molecular sciences.
[18] M. Beg,et al. In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model , 2020, Frontiers in Neuroscience.
[19] Liming Bian,et al. Early Detection of Amyloid β Pathology in Alzheimer’s Disease by Molecular MRI* , 2020, 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC).
[20] P. Tran,et al. Nano-sized solid dispersions for improving the bioavailability of poorly water-soluble drugs. , 2020, Current pharmaceutical design.
[21] S. Flora,et al. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs , 2020, Frontiers in Neuroscience.
[22] P. Shende,et al. Nanonutraceuticals: A way towards modern therapeutics in healthcare , 2020 .
[23] A. Sahebkar,et al. Neuroprotection by curcumin: a review on brain delivery strategies. , 2020, International journal of pharmaceutics.
[24] B. Wilson,et al. Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[25] F. Wandosell,et al. Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease , 2020, Frontiers in Synaptic Neuroscience.
[26] P. Maiti,et al. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s disease , 2020 .
[27] Yang Yang,et al. Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease , 2020, Journal of Nanobiotechnology.
[28] Yan Chen,et al. Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications , 2020, International journal of nanomedicine.
[29] M. Farzaei,et al. Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders , 2020, Frontiers in Bioengineering and Biotechnology.
[30] Jiejie Sun,et al. Neuronal Mitochondria-Targeted Delivery of Curcumin by Biomimetic Engineered Nanosystems in Alzheimer's Disease mice. , 2020, Acta biomaterialia.
[31] Awanish Mishra,et al. Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review , 2020, Journal of biochemical and molecular toxicology.
[32] M. Shehata,et al. Impact of nano-conjugate on Drosophila for early diagnosis of Alzheimer’s disease , 2020, Nanotechnology.
[33] B. Salehi,et al. Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases , 2020, Journal of clinical medicine.
[34] C. Lopes,et al. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[35] D. Szwajgier,et al. Alzheimer’s disease: review of current nanotechnological therapeutic strategies , 2020, Expert review of neurotherapeutics.
[36] Xing Tang,et al. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[37] Sajini D Hettiarachchi,et al. Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[38] S. Haas,et al. Curcumin-Loaded Nanocapsules Reverses the Depressant-Like Behavior and Oxidative Stress Induced by β-Amyloid in Mice , 2019, Neuroscience.
[39] S. Haas,et al. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer’s disease induced by β-amyloid 1-42 peptide in aged female mice , 2019, Brain Research.
[40] Peng Zhang,et al. Recent advances of biomimetic nano-systems in the diagnosis and treatment of tumor , 2019, Asian journal of pharmaceutical sciences.
[41] D. G. Parambi,et al. Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives , 2019, The Journal of pharmacy and pharmacology.
[42] M. Sakharkar,et al. Benefits of curcumin in brain disorders , 2019, BioFactors.
[43] Peng Zhang,et al. Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects , 2019, Asian journal of pharmaceutical sciences.
[44] M. Mozafari,et al. Preparation and characterization of curcumin‐loaded polymeric nanomicelles to interference with amyloidogenesis through glycation method , 2019, Biotechnology and applied biochemistry.
[45] M. Ghasemi-Kasman,et al. Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders , 2019, International journal of nanomedicine.
[46] F. Chien,et al. Codelivery of Plasmid and Curcumin with Mesoporous Silica Nanoparticles for Promoting Neurite Outgrowth. , 2019, ACS applied materials & interfaces.
[47] S. M. Dizaj,et al. Applications of nanotechnology in drug delivery to the central nervous system. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[48] M. González-Torres,et al. Formulations of Curcumin Nanoparticles for Brain Diseases , 2019, Biomolecules.
[49] Noureddine Raouafi,et al. Curcumin-graphene quantum dots for dual mode sensing platform: Electrochemical and fluorescence detection of APOe4, responsible of Alzheimer's disease. , 2018, Analytica chimica acta.
[50] N. Fullwood,et al. Liposome delivery systems for the treatment of Alzheimer’s disease , 2018, International journal of nanomedicine.
[51] A. Angelova,et al. Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders , 2018, Medicines.
[52] Jianqing Gao,et al. Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances , 2018, Asian journal of pharmaceutical sciences.
[53] Y. Kuo,et al. Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect β-amyloid-insulted neurons. , 2018, Materials science & engineering. C, Materials for biological applications.
[54] Ankit Parikh,et al. Curcumin-loaded self-nanomicellizing solid dispersion system: part II: in vivo safety and efficacy assessment against behavior deficit in Alzheimer disease , 2018, Drug Delivery and Translational Research.
[55] L. Moezi,et al. The Effect of BSA-Based Curcumin Nanoparticles on Memory and Hippocampal MMP-2, MMP-9, and MAPKs in Adult Mice , 2018, Journal of Molecular Neuroscience.
[56] H. Abrahamse,et al. Therapeutic Potential and Recent Advances of Curcumin in the Treatment of Aging-Associated Diseases , 2018, Molecules.
[57] Xi Zheng,et al. Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease , 2018, Neural regeneration research.
[58] Xiaoyan Dong,et al. Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid β-protein aggregation and cytotoxicity , 2018, Scientific Reports.
[59] H. Katsumi,et al. Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement. , 2018, International journal of pharmaceutics.
[60] D. Choi,et al. Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease , 2018, Drug delivery.
[61] X. Jing,et al. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease , 2018, Drug delivery.
[62] Wen-Hai Xie,et al. Neuroprotective Effects and Mechanisms of Curcumin–Cu(II) and –Zn(II) Complexes Systems and Their Pharmacological Implications , 2017, Nutrients.
[63] V. Patravale,et al. Curcumin Cocrystal Micelles-Multifunctional Nanocomposites for Management of Neurodegenerative Ailments. , 2017, Journal of pharmaceutical sciences.
[64] D. Kalman,et al. Curcumin: A Review of Its’ Effects on Human Health , 2017, Foods.
[65] M. Rosini,et al. Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule? , 2017, Pharmacological research.
[66] Shanshan Wang,et al. Synthesis and biological evaluation of curcumin analogs as β-amyloid imaging agents. , 2017, Future medicinal chemistry.
[67] Keith L Black,et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. , 2017, JCI insight.
[68] B. Zhang,et al. Biomimetic nanoparticles for inflammation targeting , 2017, Acta pharmaceutica Sinica. B.
[69] G. Tosi,et al. Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates. , 2017, International journal of pharmaceutics.
[70] C. Faustino,et al. Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer's disease , 2017, Pharmacological research.
[71] L. Gutiérrez,et al. Targeted Nanoparticles for the Treatment of Alzheimer's Disease. , 2017, Current pharmaceutical design.
[72] R. Censi,et al. Nano-medicine Improving the Bioavailability of Small Molecules for the Prevention of Neurodegenerative Diseases. , 2017, Current pharmaceutical design.
[73] N. Khashab,et al. Self-assembled lipoprotein based gold nanoparticles for detection and photothermal disaggregation of β-amyloid aggregates. , 2017, Chemical communications.
[74] Ming Ming Wen,et al. Nanotechnology‐based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[75] Yan Sun,et al. Multifunctionality of self-assembled nanogels of curcumin-hyaluronic acid conjugates on inhibiting amyloid β-protein fibrillation and cytotoxicity , 2016 .
[76] Reza Kazemi Oskuee,et al. Novel delivery system for natural products: Nano-curcumin formulations , 2016, Avicenna journal of phytomedicine.
[77] L. Freitas,et al. Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity , 2016, AAPS PharmSciTech.
[78] Sourabh Ghosh,et al. Curcumin-β-Cyclodextrin Alloy: Synergistic Effect on Aggregation Inhibition of Silk Fibroin , 2016 .
[79] A. Klymchenko,et al. Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix Composition. , 2016, Molecular pharmaceutics.
[80] R. Martins,et al. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease , 2015, British Journal of Nutrition.
[81] T. Psaltopoulou,et al. Mediterranean Diet and Risk of Dementia. , 2015, Current Alzheimer research.
[82] R. Sandhir,et al. Curcumin Nanoparticles Attenuate Neurochemical and Neurobehavioral Deficits in Experimental Model of Huntington’s Disease , 2014, NeuroMolecular Medicine.
[83] S. Vinogradov,et al. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. , 2013, Bioconjugate chemistry.
[84] Eun Kyoung Ryu,et al. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. , 2006, Journal of medicinal chemistry.
[85] Daniel Normolle,et al. Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.
[86] M. Másson,et al. Cyclodextrins in drug delivery , 2005, Expert opinion on drug delivery.
[87] Fusheng Yang,et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.
[88] M. Saladini,et al. Curcuminoids as potential new iron-chelating agents: spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability , 2002 .
[89] Yongqiang Zhang,et al. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease. , 2019, Journal of photochemistry and photobiology. B, Biology.
[90] Curcumin for Neurological and Psychiatric Disorders , 2019 .
[91] A. Azadi,et al. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence. , 2019, Journal of Alzheimer's disease : JAD.
[92] Amin Jalili,et al. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[93] Mengxi Tang,et al. The Mechanisms of Action of Curcumin in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[94] B. Ashok. Biochemical markers in Alzheimer s disease , 2008 .
[95] M. Wojewódzka,et al. DNA damage and repair in human lymphocytes and gastric mucosa cells exposed to chromium and curcumin. , 1999, Teratogenesis, carcinogenesis, and mutagenesis.